Showing results (631-640 of 2,508) with videos related to

Sort By:
Pageof 251
Endocrine-Related Cancer|August 15, 2014
Enalapril and ASS inhibit tumor growth in a transgenic mouse model of islet cell tumorsV Fendrich, C L Lopez, J Manoharan, et al.
Endocrine-Related Cancer|October 29, 2013
Autophagy and thyroid carcinogenesis: genetic and epigenetic linksFederica Morani, Rossella Titone, Loredana Pagano, et al.
Endocrine-Related Cancer|October 30, 2013
GDNF increases cell motility in human colon cancer through VEGF-VEGFR1 interactionSsu-Ming Huang, Tzu-Sheng Chen, Chien-Ming Chiu, et al.
Endocrine-Related Cancer|November 19, 2013
TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growthGarrett Daniels, Yirong Li, Lan Lin Gellert, et al.
Endocrine-Related Cancer|July 12, 2014
Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotideMatthew H Kulke, Thomas O'Dorisio, Alexandria Phan, et al.
Endocrine-Related Cancer|September 4, 2014
The LRIG family: enigmatic regulators of growth factor receptor signalingCatalina Simion, Maria Elvira Cedano-Prieto, Colleen Sweeney
Endocrine-Related Cancer|June 9, 2016
In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cellsThomas Cuny, Caroline Zeiller, Martin Bidlingmaier, et al.
Endocrine-Related Cancer|June 9, 2016
SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse modelXuguang Zhu, Dong Wook Kim, Li Zhao, et al.
Endocrine-Related Cancer|October 4, 2015
Targeting muscle signaling pathways to minimize adverse effects of androgen deprivationCasey de Rooy, Mathis Grossmann, Jeffrey D Zajac, et al.
Endocrine-Related Cancer|October 18, 2013
Calculating optimal surveillance for detection of von Hippel-Lindau-related manifestationsRoeliene C Kruizinga, Wim J Sluiter, Elisabeth G E de Vries, et al.
Pageof 251